Anticoagulation in Patients Younger Than 21 Years of Age, Semaglutide vs Liraglutide and Body Weight, COPD Screening in Low- and Middle-Income Countries, and more

JAMA Editor’s Summary

Anticoagulation in Patients Younger Than 21 Years of Age, Semaglutide vs Liraglutide and Body Weight, COPD Screening in Low- and Middle-Income Countries, and more

Editor’s Summary by Christopher Muth, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the issue.

January 11, 2022

Listen on your favorite player Take me to this show’s page

Newer →

P2Y12 Inhibitors in Non-Critically Ill Hospitalized COVID-19, US Ambulatory Care Patterns During the Pandemic, Outcomes for Extremely Preterm Infants in the US, and more

← Older

Medical Oncology Depression Screening for Breast Cancer, Anesthesia Choice and Postoperative Delirium After Hip Fracture Surgery, Maternal Hormone Contraception and CNS Tumors in Children, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Anticoagulation in Patients Younger Than 21 Years of Age, Semaglutide vs Liraglutide and Body Weight, COPD Screening in Low- and Middle-Income Countries, and more

Editor’s Summary by Christopher Muth, MD, Senior Editor of JAMA, the Journal of the American Medical Association, for the January 11, 2022 issue.

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00